MOLINA ARTURO MD Insider Trading Activity

Average Profitability
101.81%
Insider Buys Quantity
1
Insider Buys Sum
$49,995.25
Insider Sells Quantity
6
Insider Sells Sum
$3.22M

Insider Activity of MOLINA ARTURO MD

According to the SEC Form 4 filings, MOLINA ARTURO MD, being in a position of

  1. Chief Medical Officer at Protagonist Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 50377 shares for $4.49M,
    over all time since 2023-11-15, has bought 0 shares, and sold 139814 shares for $8.84M.

Biography of MOLINA ARTURO MD

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $4,491,7666100

Comparison of Insiders on Amount of Buys and Sells

2026-03-26SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
15,000
0.0241%
$104.79$1.57M+31.58%
2026-01-27SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
5,000
0.0079%
$82.00$410,000+34.75%
2026-01-26SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
5,000
0.008%
$82.28$411,400+35.41%
2026-01-23SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
13,151
0.0209%
$82.42$1.08M+33.62%
2026-01-20SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
9,514
0.015%
$82.48$784,715+31.61%
2025-11-17SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
2,712
0.0043%
$84.77$229,896+21.38%
2025-06-10SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
10,000
0.0163%
$57.03$570,300+47.65%
2025-06-09SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
10,000
0.0161%
$55.51$555,100+49.25%
2025-03-13SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
30,514
0.0505%
$55.74$1.7M+8.56%
2025-01-16SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
3,640
–
$0$0+51.12%
2024-11-27SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
26,000
0.0435%
$44.70$1.16M+16.86%
2024-11-26SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
5,529
0.0095%
$45.60$252,122+16.91%
2024-11-15SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
1,906
0.0032%
$40.98$78,108+23.3%
2023-11-15SaleProtagonist Therapeutics, Inc.
PTGX
Chief Medical Officer
1,848
0.0032%
$16.24$30,012+88.09%
2020-05-14PurchaseSutro Biopharma, Inc.
STRO
Chief Medical Officer
6,451
0.0205%
$7.75$49,995+101.81%
Total: 15
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.